Rituximab May Help in RA Lung Disease

LIVERPOOL (MedPage Today) -- Patients with rheumatoid arthritis who have interstitial lung disease (ILD) appeared to have a survival advantage if treated with rituximab rather than with a tumor necrosis factor (TNF) inhibitor, a researcher said here.
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news